Human ESC lines with point mutations in SNCA, isogenic controls, and SNCA-mutation-associated PD patient hiPSC lines have been generated to provide a platform to study perturbations in alpha-synuclein in a targeted fashion (154). This evidence concerns the gene SNCA and Parkinson disease.